Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41

Natarajan, Niranjana, Hori, Daijiro, Flavahan, Sheila, Steppan, Jochen, Flavahan, Nicholas A., Berkowitz, Dan E., Pluznick, Jennifer L.·2016·Physiological Genomics

Cited by (448)

Items 101–200 of 448

  1. Sequence meets function—microbiota and cardiovascular disease
    Myungsuk Kim, M. Nazmul Huda, Brian J. Bennett · 2021 · Cardiovascular Research
  2. Advances in pathogenesis and treatment of essential hypertension
    Jun Ma, Xiaoping Chen · 2022 · Frontiers in Cardiovascular Medicine
  3. Short-chain fatty acids are potential goalkeepers of atherosclerosis
    Yu Feng, Danyan Xu · 2023 · Frontiers in Pharmacology
  4. Nutritional approaches for managing obesity-associated metabolic diseases
    Rachel E. Botchlett, Shih‐Lung Woo, Mengyang Liu, Ya Pei, Xin Guo, Honggui Li, Chaodong Wu · 2017 · Journal of Endocrinology
  5. Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1
    Harshal Waghulde, Xi Cheng, Sarah Galla, Blair Mell, Jingwei Cai, Shondra M. Pruett‐Miller, Guillermo Vázquez, Andrew D. Patterson, Matam Vijay Kumar, Bina Joe · 2018 · Hypertension
  6. Roles of short-chain fatty acids in kidney diseases
    Ling-Zhi Li, Sibei Tao, Liang Ma, Ping Fu · 2019 · Chinese Medical Journal
  7. Anti-hypertensive and cardioprotective activities of traditional Chinese medicine-derived polysaccharides: A review
    Miaotian Xie, Weili Tao, Fengjia Wu, Kunlin Wu, Xiujie Huang, Gensong Ling, Chuanyi Zhao, Qian Lv, Qiongjin Wang, Xianhuan Zhou et al. · 2021 · International Journal of Biological Macromolecules
  8. The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans
    Jessica Maiuolo, Cristina Carresi, Micaela Gliozzi, Rocco Mollace, Federica Scarano, Miriam Scicchitano, Roberta Macrì, Saverio Nucera, Francesca Bosco, Francesca Oppedisano et al. · 2022 · International Journal of Molecular Sciences
  9. Update on gut microbiota in cardiovascular diseases
    Buyun Qian, Kaiyu Zhang, Yuan Li, Kangyun Sun · 2022 · Frontiers in Cellular and Infection Microbiology
  10. Enhanced Detection of Short‐Chain Fatty Acids Using Gas Chromatography Mass Spectrometry
    Haiwei Gu, Paniz Jasbi, Jeffrey S. Patterson, Yan Jin · 2021 · Current Protocols
  11. The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health
    Lenka Tomášová, Marian Grman, Karol Ondriaš, Marcin Ufnal · 2021 · Nutrition & Metabolism
  12. An Improved Method to Quantify Short-Chain Fatty Acids in Biological Samples Using Gas Chromatography–Mass Spectrometry
    Kyeong-Seog Kim, Yujin Lee, Woori Chae, Joo‐Youn Cho · 2022 · Metabolites
  13. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases
    Jing Xu, Yuejin Yang · 2021 · Gut Microbes
  14. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease
    B. Meijers, F. Jouret, P. Evenepoel · 2018 · Pharmacological Research
  15. Microbiome and hypertension: where are we now?
    Natalia G. Vallianou, Eleni V. Geladari, Dimitris C. Kounatidis · 2019 · Journal of Cardiovascular Medicine
  16. Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects
    Ana K. Carrizales-Sánchez, Tomás García‐Cayuela, Carmen Hernández‐Brenes, Carolina Senés‐Guerrero · 2021 · Gut Microbes
  17. Disruptive physiology: olfaction and the microbiome–gut–brain axis
    John Bienenstock, Wolfgang Kunze, Paul Forsythe · 2017 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  18. Double-side role of short chain fatty acids on host health via the gut-organ axes
    Yanan Gao, Qianqian Yao, Lu Meng, Jiaqi Wang, Nan Zheng · 2024 · Animal nutrition
  19. Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity
    Micah L. Battson, Dustin M. Lee, Lance C. Li Puma, Kayl E. Ecton, Keely N. Thomas, Hallie P. Febvre, Adam J. Chicco, Tiffany L. Weir, Christopher L. Gentile · 2019 · American Journal of Physiology-Heart and Circulatory Physiology
  20. Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr −/− .Leiden mice
    Anouk C. Tengeler, Eveline Gart, Maximilian Wiesmann, Ilse A.C. Arnoldussen, Wim van Duyvenvoorde, Marloes Hoogstad, Pieter J.W.C. Dederen, Vivienne G. M. Verweij, Bram Geenen, Tamás Kozicz et al. · 2020 · The FASEB Journal
  21. Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway
    Bo Li, Xinglishang He, Haiying Jin, Hui-Ying Wang, Fu-Chen Zhou, Ningyu Zhang, Jie Dong-ying, Lin-Zi Li, Jie Su, Xiang Zheng et al. · 2021 · Food & Function
  22. Diet-related gut microbial metabolites and sensing in hypertension
    Rikeish R. Muralitharan, Francine Z. Marques · 2020 · Journal of Human Hypertension
  23. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
  24. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development
    Jing Li, Xinchun Yang, Xin Zhou, Jun Cai · 2020 · Antioxidants and Redox Signaling
  25. Interplay between dietary phenolic compound intake and the human gut microbiome in hypertension: A cross-sectional study
    Lorena Calderón-Pérez, Elisabet Llauradó, Judit Companys, Laura Pla‐Pagà, Anna Pedret, Laura Rubió, María José Gosalbes, Sílvia Yuste, Rosa Solà, Rosa M. Valls · 2020 · Food Chemistry
  26. Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease
    Curtis L. Gabriel, Jane F. Ferguson · 2023 · Circulation Research
  27. Impact of Dietary Fiber on Inflammation in Humans
    Stefan Kabisch, Jasmin Hajir, Varvara Sukhobaevskaia, Martin O. Weickert, Andreas F. H. Pfeiffer · 2025 · International Journal of Molecular Sciences
  28. Valeric acid lowers arterial blood pressure in rats
    Maksymilian Onyszkiewicz, Marta Gawryś-Kopczyńska, Maciej Sałagaj, Marta Aleksandrowicz, Aneta Sawicka, Ewa Koźniewska, Emilia Samborowska, Marcin Ufnal · 2020 · European Journal of Pharmacology
  29. Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESC
    Gianluigi Savarese, Gabriele G. Schiattarella, Felix Lindberg, Markus S. Anker, Antoni Bayés‐Genís, Magnus Bäck, Frieder Braunschweig, Chiara Bucciarelli‐Ducci, Javed Butler, Antonio Nicola Cannata et al. · 2025 · European Journal of Heart Failure
  30. Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota
    David J. Durgan · 2017 · Current Hypertension Reports
  31. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota
    Xin Zhao, Patrick Kwabena Oduro, Wanyu Tong, Yuefei Wang, Xiumei Gao, Qilong Wang · 2020 · Pharmacological Research
  32. The critical role of short-chain fatty acids in health and disease: A subtle focus on cardiovascular disease-NLRP3 inflammasome-angiogenesis axis
    Yao Juan, Yu Chen, Ming Xu · 2022 · Clinical Immunology
  33. Maternal microbiome in preeclampsia pathophysiology and implications on offspring health
    Ishimwe, Jeanne A. · 2021 · Physiological Reports
  34. Increased Abundance of Lactobacillales in the Colon of Beta-Adrenergic Receptor Knock Out Mouse Is Associated With Increased Gut Bacterial Production of Short Chain Fatty Acids and Reduced IL17 Expression in Circulating CD4+ Immune Cells
    Bartley, Akeem, Yang, Tao, Arocha, Rebeca, Malphurs, Wendi L., Larkin, Riley, Magee, Kacy L., Vickroy, Thomas W., Zubcevic, Jasenka · 2018 · Frontiers in Physiology
  35. Water soluble dietary fiber from walnut meal as a prebiotic in preventing metabolic syndrome
    Guoliang Wang, Diying Zhong, Haohan Liu, Tao Yang, Qiqi Liang, Jing Wang, Runguang Zhang, Youlin Zhang · 2021 · Journal of Functional Foods
  36. Impact of fundamental components of the Mediterranean diet on the microbiota composition in blood pressure regulation
    Ana Karina Zambrano, Santiago Cadena-Ullauri, Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Elius Paz‐Cruz, Patricia Guevara‐Ramírez, Evelyn Frías-Toral, Daniel Simancas‐Racines · 2024 · Journal of Translational Medicine
  37. The gut–immune axis during hypertension and cardiovascular diseases
    Evany Dinakis, Joanne A. O’Donnell, Francine Z. Marques · 2024 · Acta Physiologica
  38. Discovery of metabolic biomarkers for gestational diabetes mellitus in a Chinese population
    Wenqian Lu, Mingjuan Luo, Xiangnan Fang, Rong Zhang, Shanshan Li, Mengyang Tang, Xiangtian Yu, Cheng Hu · 2021 · Nutrition & Metabolism
  39. Age-related changes of microbiota in midlife associated with reduced saccharolytic potential: an in vitro study
    Liying Zhu, Junkui Chen, Xionge Pi, Jinjun Li, Wei Liu, Qunfang Ding, Xin Wang, Weiguo Jia · 2021 · BMC Microbiology
  40. Microbiotal-Host Interactions and Hypertension
    Sarah Galla, Saroj Chakraborty, Blair Mell, Matam Vijay–Kumar, Bina Joe · 2017 · Physiology
  41. Indole-3-propionic acid, a tryptophan-derived bacterial metabolite, increases blood pressure via cardiac and vascular mechanisms in rats
    Piotr Konopelski, Dawid S. Chabowski, Marta Aleksandrowicz, Ewa Koźniewska, Piotr Podsadni, Agnieszka Szczepańska, Marcin Ufnal · 2021 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  42. Altered Gut Microbiota and Its Metabolites in Hypertension of Developmental Origins: Exploring Differences between Fructose and Antibiotics Exposure
    Chien‐Ning Hsu, Julie Y.H. Chan, Kay L. H. Wu, Hong‐Ren Yu, Wei‐Chia Lee, Chih‐Yao Hou, You‐Lin Tain · 2021 · International Journal of Molecular Sciences
  43. Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
    Qinyu Li, Bing Xin Gao, Siqin Bateer, Qian He, Ru Zhang, Xiangxi Meng, Zhang Naiheng, Minhui Li, Minhui Li · 2021 · Frontiers in Pharmacology
  44. Probiotics and Gut Microbiota in Obesity: Myths and Realities of a New Health Revolution
    Xavier León Aguilera, Alexander Manzano, Daniela Pírela, Valmore Bermúdez · 2022 · Journal of Personalized Medicine
  45. Microbiota alterations associated with vascular diseases: postbiotics as a next-generation magic bullet for gut-vascular axis
    Lorenzo Flori, Giada Benedetti, Alma Martelli, Vincenzo Calderone · 2024 · Pharmacological Research
  46. Vascular Cognitive Impairment and the Gut Microbiota
    Sinian Li, Yiming Shao, Kanglan Li, Changmei HuangFu, Wenjie Wang, Zhou Liu, Zhiyou Cai, Bin Zhao · 2018 · Journal of Alzheimer s Disease
  47. The Microbiome and Acute Kidney Injury
    Hamid Rabb, Jennifer L. Pluznick, Sanjeev Noel · 2018 · The Nephron journals/Nephron journals
  48. Polysaccharide, the Active Component of Dendrobium officinale, Ameliorates Metabolic Hypertension in Rats via Regulating Intestinal Flora-SCFAs-Vascular Axis
    Bo Li, Huiying Wang, Jia-Hui Huang, Wanfeng Xu, Xiao-Jie Feng, Ze-Ping Xiong, Yingjie Dong, Lin-Zi Li, Xinglishang He, Han-Song Wu et al. · 2022 · Frontiers in Pharmacology
  49. Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review
    Eline Birkeland, Sedegheh Gharagozlian, Jørgen Valeur, Anne‐Marie Aas · 2023 · Lipids in Health and Disease
  50. Impact of Gut Microbiota on the Peripheral Nervous System in Physiological, Regenerative and Pathological Conditions
    Sonia Calabrò, Svenja Kankowski, Matilde Cescon, Giovanna Gambarotta, Stefania Raimondo, Kirsten Haastert‐Talini, Giulia Ronchi · 2023 · International Journal of Molecular Sciences
  51. Probiotics: functional food ingredients with the potential to reduce hypertension
    Zouquan Chen, Wanjie Liang, Jie Liang, Jiaxin Dou, Fangyu Guo, Daolei Zhang, Zhenshang Xu, Ting Wang · 2023 · Frontiers in Cellular and Infection Microbiology
  52. Gut Microbiota and Cardiovascular Diseases
    Gaia Anselmi, Lucilla Gagliardi, Gabriele Egidi, Sabrina Leone, Antonio Gasbarrini, Giacinto Abele Donato Miggiano, Leonarda Galiuto · 2020 · Cardiology in Review
  53. Altered Salivary Microbiota in Patients with Obstructive Sleep Apnea Comorbid Hypertension
    Xuehui Chen, Yanlong Chen, Mengqi Feng, Xin Huang, Changtao Li, Fang Han, Qian Zhang, Xuemei Gao · 2022 · Nature and Science of Sleep
  54. Fasting intervention and its clinical effects on the human host and microbiome
    Sofia Kirke Forslund · 2022 · Journal of Internal Medicine
  55. Short-chain fatty acid delivery: assessing exogenous administration of the microbiome metabolite acetate in mice
    Tyler B. Shubitowski, Brian G. Poll, Niranjana Natarajan, Jennifer L. Pluznick · 2019 · Physiological Reports
  56. The Combination of Scutellaria baicalensis Georgi and Sophora japonica L. ameliorate Renal Function by Regulating Gut Microbiota in Spontaneously Hypertensive Rats
    Yiqing Guan, Kai Chen, Dongling Quan, Liangqi Kang, Dan‐Ni Yang, Huanxian Wu, Mengqiu Yan, Shaoyu Wu, Lin Lv, Guohua Zhang · 2021 · Frontiers in Pharmacology
  57. The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure
    Yusuke Sata, Francine Z. Marques, David M. Kaye · 2020 · Current Hypertension Reports
  58. Short-Chain Carbon Sources
    Azariyas A. Challa, E. Douglas Lewandowski · 2022 · JACC Basic to Translational Science
  59. Resveratrol and the Interaction between Gut Microbiota and Arterial Remodelling
    Andy W. C. Man, Huige Li, Ning Xia · 2020 · Nutrients
  60. The role of diet-derived short-chain fatty acids in regulating cardiac pressure overload
    Nikolai V. Pakhomov, John Andrew Baugh · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  61. Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut
    Tyler Alexander Cookson · 2021 · Frontiers in Cardiovascular Medicine
  62. The Role of Gut Microbiota in Hypertension Pathogenesis and the Efficacy of Antihypertensive Drugs
    Yanling Xiong, Yalan Xiong, Peng Zhu, Yusheng Wang, Haijun Yang, Rong Zhou, Yan Shu, Hong‐Hao Zhou, Qing Li · 2021 · Current Hypertension Reports
  63. The Gut Microbiota and Vascular Aging: A State-of-the-Art and Systematic Review of the Literature
    Davide Agnoletti, Federica Piani, Arrigo F.G. Cicero, Claudio Borghi · 2022 · Journal of Clinical Medicine
  64. Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites
    Saroj Chakraborty, Anju Lulla, Xi Cheng, Ji‐Youn Yeo, Juthika Mandal, Tao Yang, Xue Mei, Piu Saha, Rachel M. Golonka, Beng San Yeoh et al. · 2023 · Journal of Hypertension
  65. Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders
    Xiaokang Jia, Qiliang Chen, Hui‐Wen Wu, Hongbo Liu, Chunying Jing, Aimin Gong, Yuanyuan Zhang · 2023 · Frontiers in Nutrition
  66. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives
    Panagiotis Papadopoulos, Christina Tsigalou, Pipitsa N. Valsamaki, Theocharis G. Konstantinidis, Chrysoula Chrysa Voidarou, Eugenia Bezirtzoglou · 2022 · Biomedicines
  67. The propionate-GPR41 axis in infancy protects from subsequent bronchial asthma onset
    Takashi K. Ito, Yumiko Nakanishi, Ryohei Shibata, Noriko Sato, Toshi Jinnohara, Sayo Suzuki, Wataru Suda, Masahira Hattori, Ikuo Kimura, Taiji Nakano et al. · 2023 · Gut Microbes
  68. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation
    Gregory J. Weber, Jaleyea Foster, Sathnur Basappa Pushpakumar, Utpal Sen · 2018 · Pharmacological Research
  69. Role of gut metabolism of adrenal corticosteroids and hypertension: clues gut-cleansing antibiotics give us
    David J. Morris, Andrew S. Brem · 2019 · Physiological Genomics
  70. Influence of fermented soy protein consumption on hypertension and gut microbial modulation in spontaneous hypertensive rats
    Eric Banan‐Mwine Daliri, Fred Kwame Ofosu, Ramachandran Chelliah, Byong H. Lee, Hongyan An, Fazle Elahi, Kaliyan Barathikannan, Joong‐Hark Kim, Deog‐Hwan Oh · 2020 · Bioscience of Microbiota Food and Health
  71. Improvement of intestinal flora: accompany with the antihypertensive effect of electroacupuncture on stage 1 hypertension
    Jun‐Meng Wang, Mingxiao Yang, Qiaofeng Wu, Ji Chen, Shu-fang Deng, Lin Chen, Daneng Wei, Fanrong Liang · 2021 · Chinese Medicine
  72. Gut microbiota in hypertensive patients with versus without obstructive sleep apnea
    Dasheng Lu, Shaodong Xu, Ping Dai, Lijuan Wu, Hongxiang Zhang, Birong Zhou · 2022 · Journal of Clinical Hypertension
  73. Untapped potential of gut microbiome for hypertension management
    Kan Gao, Pengshuo Wang, Xue Mei, Tao Yang, Kai Yu · 2024 · Gut Microbes
  74. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases
    Suraphan Panyod, Wei-Kai Wu, Chieh‐Chang Chen, Ming‐Shiang Wu, Chi‐Tang Ho, Lee‐Yan Sheen · 2021 · Journal of Traditional and Complementary Medicine
  75. Intestinal microbiota: A promising therapeutic target for hypertension
    Dating Sun, Hui Xiang, Jiangtao Yan, Liqun He · 2022 · Frontiers in Cardiovascular Medicine
  76. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
    Junwen Zhu, Jin Lyu, Ruochi Zhao, Gang Liu, Shuangshuang Wang · 2023 · Frontiers in Microbiology
  77. Key Insights into Gut Alterations in Metabolic Syndrome
    Adrian Boicean, Cristian Ichim, Sabina-Maria Sasu, Samuel Bogdan Todor · 2025 · Journal of Clinical Medicine
  78. The microbiome
    Elvedin Luković, Vivek K. Moitra, Daniel E. Freedberg · 2019 · Current Opinion in Anaesthesiology
  79. The effect of gut microbiota dysbiosis on patients with preeclampsia
    Yefang Zhao, Bingjie Wang, Xiaoling Zhao, Dan Cui, Shaoke Hou, Hongzhen Zhang · 2023 · Frontiers in Cellular and Infection Microbiology
  80. Regular Consumption of Cocoa and Red Berries as a Strategy to Improve Cardiovascular Biomarkers via Modulation of Microbiota Metabolism in Healthy Aging Adults
    Joaquín García-Cordero, Alba Martínez-Escudé, Carlos Blanco-Valverde, Alicia Pino, Verónica Puertas‐Martín, Ricardo San Román, Sonia de Pascual‐Teresa · 2023 · Nutrients
  81. Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics
    Seyed Sadeq Mousavi Ghahfarrokhi, Mohamadsadegh Mohamadzadeh, Nasrin Samadi, Mohammad Reza Fazeli, Sara Khaki, Bahman Khameneh, Ramin Khameneh Bagheri · 2024 · Current Nutrition Reports
  82. Inflammation and Arterial Stiffness as Drivers of Cardiovascular Risk in Kidney Disease
    Lorenzo Lo Cicero, Paolo Luca Maria Lentini, Concetto Sessa, Niccolò Castellino, Ambra D’anca, Irene Torrisi, Carmelita Marcantoni, Pietro Castellino, Domenico Santoro, Luca Zanoli · 2024 · Cardiorenal Medicine
  83. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease
    Mark A. Bryniarski, Fares Hamarneh, Rabi Yacoub · 2019 · Experimental Biology and Medicine
  84. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases
    Suganya Kanmani, Taekwon Son, Kyu‐Won Kim, Byung‐Soo Koo · 2020 · Microbial Pathogenesis
  85. Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
    Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun · 2020 · Microbial Pathogenesis
  86. Identifying the localization and exploring a functional role for Gprc5c in the kidney
    Premraj Rajkumar, Boyoung Cha, Jianyi Yin, Lois Johanna Arend, Teodor G. Păunescu, Yoshio Hirabayashi, Mark Donowitz, Jennifer L. Pluznick · 2017 · The FASEB Journal
  87. Renal Sensing of Bacterial Metabolites in the Gut-kidney Axis
    Orestes Foresto‐Neto, Bruno Ghirotto, Niels Olsen Saraiva Câmara · 2021 · Kidney360
  88. Constipation is associated with an increased risk of major adverse cardiac events in a UK population
    Tenghao Zheng, Letícia Camargo Tavares, Mauro D’Amato, Francine Z. Marques · 2024 · American Journal of Physiology-Heart and Circulatory Physiology
  89. Berry-Enriched Diet in Salt-Sensitive Hypertensive Rats: Metabolic Fate of (Poly)Phenols and the Role of Gut Microbiota
    Andréia Gomes, Carole Oudot, Alba Macià, Alexandre Foito, Diogo Carregosa, Derek Stewart, Tom Van de Wiele, David Berry, María‐José Motilva, Catherine Brenner et al. · 2019 · Nutrients
  90. Understanding connections and roles of gut microbiome in cardiovascular diseases
    Ethendhar Rajendiran, Balamurugan Ramadass, Vanu Ramkumar Ramprasath · 2020 · Canadian Journal of Microbiology
  91. The Gut Microbiota and Their Metabolites in Human Arterial Stiffness
    Evany Dinakis, Michael E. Nakai, Paul A. Gill, Stephanie R Yiallourou, Yusuke Sata, Jane G. Muir, Melinda Jane Carrington, Geoffrey A. Head, David M. Kaye, Francine Z. Marques · 2021 · Heart Lung and Circulation
  92. The Role of Gut Microbiota and Its Metabolites in Patients with Heart Failure
    Krzysztof Cienkowski, Alicja Cienkowska, Karolina Kupczyńska, Agata Magdalena Bielecka-Dabrowa · 2024 · Biomedicines
  93. New Insights into Stroke Prevention and Treatment: Gut Microbiome
    Linna Zhao, Liji Yang, Yuying Guo, Jie Xiao, Junping Zhang, Shixin Xu · 2021 · Cellular and Molecular Neurobiology
  94. Olfactory receptor 78 modulates renin but not baseline blood pressure
    Brian G. Poll, Jiaojiao Xu, Kunal Gupta, Tyler B. Shubitowski, Jennifer L. Pluznick · 2021 · Physiological Reports
  95. Role of G-protein coupled receptors in cardiovascular diseases
    Yuanqiang Li, Boyu Li, Weidong Chen, Yan‐Dong Wang · 2023 · Frontiers in Cardiovascular Medicine
  96. Free Fatty Acids and Free Fatty Acid Receptors: Role in Regulating Arterial Function
    Fengzhi Yu, Boyi Zong, Lili Ji, Peng Sun, Dandan Jia, Ru Wang · 2024 · International Journal of Molecular Sciences
  97. Potential Therapeutic Effects of Exogenous Ketone Supplementation for Type 2 Diabetes: A Review
    Jeremy James Walsh, Étienne Myette‐Côté, Helena Neudorf, Jonathan P. Little · 2020 · Current Pharmaceutical Design
  98. Immunoregulatory Effect of Short-Chain Fatty Acids from Gut Microbiota on Obstructive Sleep Apnea-Associated Hypertension
    Li Zhang, Chih‐Yuan Ko, Yi-Ming Zeng · 2022 · Nature and Science of Sleep
  99. Modulation of the Gastrointestinal Microbiome with Nondigestible Fermentable Carbohydrates To Improve Human Health
    Edward C. Deehan, Rebbeca M. Duar, Anissa M. Armet, María Elisa Pérez-Muñoz, Mingliang Jin, Jens Walter · 2018 · ASM Press eBooks
  100. Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives
    Oxana M. Drapkina, Adel A. Yafarova, A. N. Kaburova, Anton R. Kiselev · 2022 · Biomedicines